To determine whether p53 and Bcl-2 contribute to apoptotic activities, we probed the expression pattern of p53, Bcl-2 and Annexin V in human CRC pre and post-FOLFOX treatment and in rat-bearing CRC treated with aspirin alone and aspirin plus FOLFOLX in different combinations. This evidence concerns the gene TP53 and colorectal carcinoma.